NASDAQ:MNKD
MannKind Corporation Stock News
$4.75
-0.0500 (-1.04%)
At Close: Jun 17, 2024
WESTLAKE VILLAGE, Calif., June 28, 2021 /PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD) appreciates the recent efforts of the Centers for Medicare and Medicaid Services (CMS) in conjunction with
MannKind Presents Two Posters At American Diabetes Association's Virtual 81st Scientific Sessions, June 25-29
11:35am, Friday, 25'th Jun 2021
WESTLAKE VILLAGE, Calif., June 25, 2021 /PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD), which focuses on the development of innovative medicines for patients with endocrine and orphan lung disea
MNKD Stock Price Increases Over 7% Pre-Market: Why It Happened
08:54am, Wednesday, 16'th Jun 2021
The stock price of MannKind Corporation (NASDAQ: MNKD) increased by over 7% pre-market. This is why it happened.
DANBURY, Conn., June 16, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) and United Therapeutics Corporation (Nasdaq: UTHR) reached a major milestone today with the announcement that the
MannKind Corporation (MNKD) Management Presents at Lytham Partners Summer 2021 Investor Conference (Transcript)
03:19pm, Monday, 14'th Jun 2021
MannKind Corporation (MNKD) Management Presents at Lytham Partners Summer 2021 Investor Conference (Transcript)
MannKind and Thirona Bio Join Forces to Evaluate Potential Inhaled Therapy for Fibrotic Lung Diseases
06:15am, Thursday, 10'th Jun 2021
MannKind will conduct formulation and preclinical studies of a new chemical entity owned by Thirona
MannKind Corporation at the Lytham Partners Summer 2021 Investor Conference
05:00pm, Tuesday, 08'th Jun 2021
WESTLAKE VILLAGE, Calif., June 08, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for patients
WESTLAKE VILLAGE, Calif., June 3, 2021 /PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD), which focuses on the development of innovative medicines for patients with endocrine and orphan lung disease
MannKind Corporation's (MNKD) CEO Michael Castagna Presents at 2021 RBC Capital Markets Global Healthcare Conference (Transcript)
10:33pm, Tuesday, 18'th May 2021
MannKind Corporation's (MNKD) CEO Michael Castagna Presents at 2021 RBC Capital Markets Global Healthcare Conference (Transcript)
Best Penny Stocks To Buy According To Analysts, 1 With 95% Target
12:29pm, Friday, 14'th May 2021
Analysts expect big moves from these penny stocks. The post Best Penny Stocks To Buy According To Analysts, 1 With 95% Target appeared first on Penny Stocks to Buy, Picks, News and Information | Penny
MannKind Corporation (MNKD) CEO Michael Castagna on Q1 2021 Results - Earnings Call Transcript
01:16pm, Thursday, 13'th May 2021
MannKind Corporation (MNKD) CEO Michael Castagna on Q1 2021 Results - Earnings Call Transcript
MannKind Announces Partnership With Type 1 Diabetes IndyCar Driver Conor Daly
09:00am, Thursday, 13'th May 2021
WESTLAKE VILLAGE, Calif. and INDIANAPOLIS, May 13, 2021 /PRNewswire/ -- MannKind Corporation (Nasdaq: MNKD) is revved up to announce a partnership for the 2021 season with NTT INDYCAR SERIES driver Co
MannKind: Q1 Earnings Insights
04:59pm, Wednesday, 12'th May 2021
Shares of MannKind (NASDAQ:MNKD) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share fell 25.00% over the past year to ($0.05), which missed the es
MannKind Corporation Reports 2021 First Quarter Financial Results
04:00pm, Wednesday, 12'th May 2021
Conference Call to Begin Today at 5:00 PM ET
A Preview Of MannKind's Earnings
10:16am, Tuesday, 11'th May 2021
MannKind (NASDAQ:MNKD) announces its next round of earnings this Wednesday, May 12. Here is Benzinga's everything-that-matters guide for this Wednesday's Q1 earnings announcement.